Zacks: Brokerages Expect Medidata Solutions Inc (MDSO) Will Announce Earnings of $0.36 Per Share
Wall Street brokerages expect that Medidata Solutions Inc (NASDAQ:MDSO) will post $0.36 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Medidata Solutions’ earnings, with the lowest EPS estimate coming in at $0.29 and the highest estimate coming in at $0.46. Medidata Solutions posted earnings of $0.41 per share in the same quarter last year, which would suggest a negative year over year growth rate of 12.2%. The business is scheduled to issue its next quarterly earnings report on Thursday, February 14th.
According to Zacks, analysts expect that Medidata Solutions will report full year earnings of $1.63 per share for the current fiscal year, with EPS estimates ranging from $1.54 to $1.72. For the next financial year, analysts forecast that the business will report earnings of $1.85 per share, with EPS estimates ranging from $1.67 to $2.00. Zacks’ earnings per share averages are an average based on a survey of research analysts that cover Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Thursday, October 18th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The firm had revenue of $163.41 million for the quarter, compared to the consensus estimate of $162.09 million. During the same period in the previous year, the firm posted $0.33 EPS. The business’s quarterly revenue was up 17.6% on a year-over-year basis.
Medidata Solutions stock opened at $72.45 on Friday. Medidata Solutions has a twelve month low of $59.60 and a twelve month high of $88.87. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.52 and a current ratio of 2.52. The stock has a market capitalization of $4.43 billion, a PE ratio of 85.24, a price-to-earnings-growth ratio of 4.28 and a beta of 1.30.
In related news, EVP Michael I. Otner sold 7,030 shares of Medidata Solutions stock in a transaction dated Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the completion of the transaction, the executive vice president now directly owns 62,548 shares of the company’s stock, valued at approximately $4,340,831.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.70% of the stock is currently owned by insiders.
Several hedge funds have recently added to or reduced their stakes in MDSO. Man Group plc purchased a new stake in Medidata Solutions in the 3rd quarter valued at about $205,000. Quantbot Technologies LP purchased a new stake in Medidata Solutions in the 3rd quarter valued at about $229,000. World Asset Management Inc purchased a new stake in Medidata Solutions in the 2nd quarter valued at about $235,000. Zeke Capital Advisors LLC purchased a new stake in Medidata Solutions in the 2nd quarter valued at about $239,000. Finally, First Republic Investment Management Inc. purchased a new stake in Medidata Solutions in the 2nd quarter valued at about $242,000.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.